Search results
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 11 hours agoPerformance of an Industry Player Ionis Pharmaceuticals belongs to the Zacks Medical - Drugs...
Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
Zacks via Yahoo Finance· 11 hours agoLicensing and other revenues came in at $9.3 million, up 55% year over year. Research and...
All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy
Zacks via Yahoo Finance· 11 hours agoCyclacel Pharmaceuticals (CYCC) might move higher on growing optimism about its earnings prospects,...
West Pharmaceutical Services, Inc. (NYSE:WST): The Best Dividend Aristocrat Stock According to...
Insider Monkey via Yahoo Finance· 8 hours agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Andrew Left of Citron Research Says 'The Prosecution of Trump Appears to Be Driven by Political...
Benzinga via Yahoo Finance· 6 days agoAndrew Left of Citron Research, which rose to fame for their role in exposing Valeant ...
Stakeholders question federal drug discount program at Michigan House Insurance hearing
Michigan Advance via Yahoo News· 8 hours agoWhile the House Insurance and Financial Services Committee only had one item on its agenda on...
Jazz Pharmaceuticals stock maintains Outperform rating By Investing.com
Investing.com· 15 hours agoOn Thursday, RBC (TSX:RY) Capital Markets sustained its Outperform rating and $176.00 price target...
Takeda Pharmaceutical Co ADR (TAK) gets rating Upgrade from BofA Securities – Knox Daily
Knox Daily· 4 days agoBofA Securities upgraded its Takeda Pharmaceutical Co ADR [TAK] rating to a Buy from a a Neutral in a research note published recently. A number of analysts ...
AstraZeneca completes Fusion Pharmaceuticals acquisition
Pharmaceutical Technology via Yahoo Finance· 2 days agoThis could result in more effective cancer cell destruction while minimising damage to surrounding...
Chad Gassert Sells 20,000 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock
ETF DAILY NEWS· 22 hours agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) SVP Chad Gassert sold 20,000 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was ...